Beyond Celiac Coalition and FDA Discuss Pediatric Clinical Trial Barriers for Celiac Disease
The Beyond Celiac Coalition recently convened with the FDA to address barriers in pediatric clinical trials for celiac disease. PHILADELPHIA, PA, UNITED STATES, July 28, 2026 / EINPresswire.com / — The Beyond Celiac Coalition is a collaboration of multidisciplinary stakeholders working to develop potential treatments for celiac disease. The coalition recently participated in a multi-stakeholder meeting with the FDA, pediatric celiac disease patients and their parents to discuss a collaborative and patient-centric approach to developing pediatric therapeutic trials for celiac disease. Participating in clinical trials is necessary to accelerate research for treatment breakthroughs and efforts to find a cure.
The text below was supplied by the Scoop Newsroom app. Third-party reporting is attributed in the source panel.
Proactively addressing these considerations now will ensure that children are not left behind as new treatments are developed,” said Debra Silberg, MD, PhD, Chief Scientific Officer at Beyond Celiac.
Dated changes to this report are shown here as they are published.
Version 4updated
The Beyond Celiac Coalition recently convened with the FDA to address barriers in pediatric clinical trials for celiac disease. PHILADELPHIA, PA, UNITED STATES, July 28, 2026 / EINPresswire.com / — The Beyond Celiac Coalition is a collaboration of multidisciplinary stakeholders working to develop potential treatments for celiac disease. The coalition recently participated in a multi-stakeholder meeting with the FDA, pediatric celiac disease patients and their parents to discuss a collaborative and patient-centric approach to developing pediatric therapeutic trials for celiac disease. Participating in clinical trials is necessary to accelerate research for treatment breakthroughs and efforts to find a cure.